Conditioned medium from human cord blood mesenchymal stem cells attenuates age-related immune dysfunctions

doi:10.21203/rs.3.rs-1205200/v1

Download PDF

Research Article

Conditioned medium from human cord blood mesenchymal stem cells attenuates age-related immune dysfunctions

https://doi.org/10.21203/rs.3.rs-1205200/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Aging is accompanied with progressive deterioration of immune responses and tissues function. Using 12-month old mice as model, we showed that conditioned medium of human cord blood mesenchymal stem cells (CBMSC-CM) significantly reduced the population percentage of CD3-CD335 + NK and CD4 + CD25 + regulatory T cells in peripheral blood. The CBMSC-CM administration also increased naïve T cells number and restored the ratio of naïve to memory T cells in CD4 + T cells population. These results indicated that CBMSC-CM improved the immune response efficiency of aged mice. Moreover, we also found CBMSC-CM treatment significantly reduced the number of senescent cells in kidney tissues. Finally, we demonstrated that CBMSC-CM remarkably attenuated hydrogen peroxide triggered T cell response and ameliorated oxidative stress induced cellular senescence. All of these data suggest a prominent anti-aging effect of secretome of CBMSCs.

Cord blood

mesenchymal stem cells

immune regulation

oxidative damage

anti-aging

Aging profoundly increases the risk to many diseases such as cancer, diabetes, cardiovascular diseases and neurological disorders, etc. This is mainly due to the progressive decline of organs and tissues functions induced by accumulation of cellular damage^1–4. Particularly, most of the age-related diseases are associated with chronic inflammation, which can be partially attributed to the dysfunctional immune system with aging. The functional decline of immune system with aging, which is referred to as “immunosenescence” not only increases the risk to infectious disease but also contributes to many degenerative diseases, such as neurodegeneration, cancer, cardiovascular and autoimmune disease^5–8.

Mesenchymal stem cells (MSCs) are characterized as stromal stem cells or precursors with multipotent differentiation properties⁹. They have been identified in different post-natal organs and tissues including brain, spleen, liver, kidney, lung, bone marrow, muscle, etc. ¹⁰. Although the exact functions of MSCs in vivo are still not clear, present studies suggest that they participate in tissue regeneration and play important roles in supporting neighboring progenitor cells and maintaining tissue homeostasis ^11,12. The biological functions of MSCs also decline with age, which inevitably impairs the tissue regeneration capacity^13,14. Therefore, a rejuvenation of the MSCs’ activity is speculated as a promising strategy to improve functions of old tissues. To support this hypothesis, transplantation of young MSCs were found to slow the loss of bone density and even prolonged the life span of old mice^15,16. A recent study also demonstrated that transplantation of umbilical cord derived MSCs reversed cognitive aging of old mic¹⁷. These studies indicate the anti-aging potential of MSCs. Considering the outstanding immune modulation functions of MSCs, whether MSCs could play a beneficial role in restoring age-related immune dysfunctions is an intriguing question that remains unanswered.

Extensive evidences showed that the biological functions of MSCs largely rely on their paracrine secretion property. MSCs secrete various bioactive compounds, including cytokines, remodeling factors and extracellular vesicles. Secretion of these factors is considered to be vital important to the trophic support and immune modulation functions of MSCs^18,19. Therefore, it can be suggested that the secretome of MSCs may be responsible for their anti-aging effect.

In this study, we explored the anti-aging effect of MSCs derived conditioned medium (CM). The human umbilical cord blood (CB) has provided a fetal source of MSCs, which preserve a superior secretory function ²⁰. By a middle-aged mice model, we evaluated the effect of CBMSC-CM on the immunoregulatory functions and tissue aging of mice. In vitro, we also showed that CBMSC-CM attenuated hydrogen peroxide triggered T cell response and protected stromal cells from oxidative stress induced cellular senescence.

Conditioned medium from CBMSCs improved immunoregulatory functions of middle-aged mice

Our present study focused on the anti-aging effect of cytokine compounds from CBMSCs. The conditioned medium from CBMSCs (CBMSC-CM) was processed by ultracentrifuge to exclude the effect of extracellular vesicles. The CBMSC-CM was also concentrated by ultrafiltration to enrich the effective constituent and to reduce the interference of volume.

To determine whether CBMSC-CM could attenuate age-related immunosenescence in vivo, we evaluated the effect of CBMSC-CM on immune cell subpopulations of peripheral blood in a middle-aged mice model.

As the reduced levels of T and B cells population were taken as a hallmark of aging, we first detected the T, B and myeloid cells percentage in the peripheral blood. There were no significant changes in the ratio of T, B and myeloid cells in control and CBMSC-CM treated group. Moreover, the T and B cells population from peripheral blood still maintained a high level in the old mice (Fig. 1). This result may be explained by that the 12-month-old C57Bl/6 mice were still in a middle-aged state, which did not come into a serious immunosenescence.

Acting as an immune surveillance role against damaged cells such as senescent cells, natural killer cells (NK cells) have been reported changing in number and function with aging[14]. We detected the level of CD3-CD335 + NK cells population in the peripheral blood of mice treated with control or CBMSC-CM. The result showed that CBMSC-CM treatment significantly decreased the percentage of NK cells population in peripheral blood (Fig. 2A, B).

Regulatory T cells (Tregs) maintains peripheral tolerance and act as critical negative regulators of inflammation^22–24. Aging has been reported to be associated with increased Tregs numbers. Therefore, the level of Tregs was detected by measuring the CD4 + CD25 + subpopulations in the CD3 + T cells. The result showed that CBMSC-CM treatment significantly decreased the level of Tregs in peripheral blood (Fig. 2C, D).

The decrease of naïve/memory T cell ratio with aging reflects the destruction of T cell homeostasis. We found that CBMSC-CM treatment significantly increased the CD44-CD62L + naïve T cell population and decreased the CD44 + CD62L- memory T cell population in the CD3 + CD4 + subgroup of peripheral blood (Fig. 3A, B). Therefore, compared to the control group, mice treated with CBMSC-CM maintained a higher ratio of naïve/memory T cells in peripheral blood (Fig. 3C).

Conditioned medium from CBMSCs ameliorated kidney aging of middle-aged mice

To explore the effect of CBMSC-CM on other tissues in old mice, we further investigated the age-related phenotypes of representative tissues in old mice. Using P16 and SA-β-gal as markers, we labeled the senescent cells of heart, liver, lung and kidney tissues. The tissue cells in heart, liver and lung neither exhibited significant senescence phenotypes, nor showed any difference between control and experimental groups. In the kidney tissues we detected a high level of P16 expression and SA-β-gal staining, which suggested a profound aging of kidney. However, CBMSC-CM treatment significantly ameliorated the aging of kidney as detected by lower P16 expression and SA-β-gal staining (Fig. 4).

Conditioned medium from CBMSCs attenuated hydrogen peroxide triggered T cell response

The increased production of hydrogen peroxide (H₂O₂) is a major clue of aging process and has been demonstrated to play an essential role in driving age-related inflammation and tissue cell damage^25,26. We postulated that secretome released from young MSCs harbors factors protecting oxidative stress. Therefore, we next investigated whether CBMSC-CM treatment ameliorated H₂O₂ induced oxidative stress. The human T lymphocyte derived Jurkat cells were exposed to different concentrations of H₂O₂ for six hours and cultured for another 18 hours with medium containing 10% fresh control or CBMSC-CM. Interestingly, although high concentrations of H₂O₂ (> 20µM) significantly reduced the cell viability of Jurkat cells, low concentrations of H₂O₂ (< 10µM) were shown to promote Jurkat cells proliferation. However, when treated with CBMSC-CM, the promotion proliferation effect induced by H₂O₂ was remarkably repressed (Fig. 5A). These results indicated that CBMSC-CM attenuated T cell response triggered by H₂O₂.

Conditioned medium from CBMSCs attenuated oxidative stress-induced cellular senescence

As in tissue stromal cells, a low concentration of H₂O₂ treatment is observed to trigger cellular senescence, we investigated whether CBMSC-CM played a role in protecting tissue stromal cells from oxidative stress induced cellular senescence. CBMSCs were pretreated with 200µM H₂O₂ for two hours to expose to a oxidative challenge. Then the cells were incubated with fresh medium or medium supplemented with CM from young CBMSCs. After three days culture, the total reactive oxygen species (ROS) level of cells was measured by DCF probe. The results showed that pretreatment of H₂O₂ significantly increased the ROS level of CBMSCs. However, when treated with different concentrations of CBMSC-CM, there was a reduction trend of the ROS level in the cells and a 10% CBMSC-CM treatment showed significantly effective to reduce the ROS level of cells close to the untreated level (Fig. 5B, C). We next evaluated the senescence state of cells by SA-β-gal staining. Pretreatment of H₂O₂ significantly increased the activity of SA-β-gal in the cells, which suggested a premature senescence. As we expected, treatment of 10% CBMSC-CM remarkably reduced the SA-β-gal activity in the cells (Fig. 5D, E). As the PI3K/AKT signaling pathway provides important signal for the survival and growth of cells in response to oxidative stress, we evaluated the activity of serine/threonine kinase Akt. The result showed that CBMSC-CM treatment increased the level of pAkt while decreased the expression of P16 in response to H₂O₂ induction (Fig. 5F). Therefore, CBMSC-CM treatment promoted the activity PI3K/AKT signaling pathway. These results implied that CBMSC-CM contained bioactive compounds that attenuated oxidative stress-induced cellular senescence.

In the present study, we found that the CBMSC-CM improved the immunoregulatory functions of old mice as evidenced by beneficial changes of NK cells, regulatory T cells, and memory and naïve T cells. We also confirmed that CBMSC-CM treatment reduced the rate of senescent cells in kidney tissue, which implied a delay of its aging process and improvement of its function. In vitro, we demonstrated that CBMSC-CM attenuated hydrogen peroxide induced T cells response and prevented cells from oxidative stress induced cellular senescence. These results highlight the anti-aging activity exerted by CBMSC-CM.

Numerous studies have indicated that MSCs play essential roles in tissue regeneration processes. These data suggest that the activity of MSCs profoundly influences the neighboring stem cell niche and systemic milieu^27–29. It has become evident that the secretome of MSCs accounts for these biological functions. Although extracellular vesicles secreted by MSCs are taken as important factors, they have been depleted from the conditioned medium in this experiment. Whether treatment of extracellular vesicles plays roles in improving age-related functional deterioration is an intriguing question under investigation. Nevertheless, in this study we focused on the anti-aging functions of soluble proteins secreted by MSCs.

Age-related changes of the immune system involve in the innate part and the adaptive part. As representative of the innate part, NK cells contribute to the first line of defense against infections. Numerous studies confirmed that there is a significant increase in the percentage and/or absolute number of total NK cells with aging. This age-related increase in number can be taken as a compensation of the defective functions of NK cells^30–34. In our study, an in vivo administration of CBMSC-CM significantly reduced the CD3-CD335 + NK cells. This indicated an improvement of innate immunity in the aged mice.

The age-related alteration of T cell compartment could profoundly affect the adaptive immune response of aged population³⁵. Although the immune modulation functions of MSCs often refer to their suppressive effect, our results found that the CD4 + CD25 + Tregs in peripheral blood of aged mice were remarkably repressed by CBMSC-CM administration. Aging has been found associated with enhanced functions of Tregs, although the related mechanism remains unknown. Some studies support that the increased activity of Tregs with aging may be attributed to the long-term stimulation of inflammatory signals from damaged tissues. According to this theory, more Tregs are taken as a positive feedback to age-related degeneration^36,37. Despite its beneficial aspect, a high level of Tregs activity could attenuate the immune surveillance and increase body’s risk to cancer³⁸. An intriguing question that remains to be uncovered is whether the increase number of Tregs came from the direct regulation by factors from CBMSC-CM, or is a response to improved inflammatory environment.

In our study, CBMSC-CM treatment significantly increased the level of naïve T cells population in middle-aged mice. Age-related naïve T cell defects has been taken as a prominent hallmark of immunosenescence and the reason can be attributed to thymic involution[24]. As the maturation site of T cells, thymus undergoes profound atrophy with aging. This results in less efficient T cell development and decreased emigration of naïve T cells to the periphery. The decreased number of naïve T cells disturbs the diversity of TCR repertoire, which impairing the response capacity of immune system to external infections. Studies have proposed that the functional decline of thymic stromal cells could account for thymic involution. It has been discovered that some crucial cytokines produced by thymic stromal cells such as G-CSF, GM-CSF, IL-7, M-CSF and SCF drive thymic involution³⁹. Therefore, our results indicated that CBMSC-CM attenuated the thymic involution in aged mice and this may be due to the improved thymus microenvironment.

Our results showed that the tissue cells in heart, liver and lung exhibited no significant senescence phenotypes. This may be the reason that the 12-month old mice were still in a middle-aged state and the low aging state of heart, liver and lung tissues counteracted the effect of CBMSC-CM. Nevertheless, we have found that CBMSC-CM administration significantly reduced the number of senescent cells in kidney. The immune cells is responsible for the clearance of senescent cells of old tissues. The accumulation of senescent cells in organs and tissues can be partially explained by the reduced efficiency of senescent cell clearance by immune system^40,41. Therefore, the more efficient immune response improved by CBMSC-CM may be responsible for the ameliorated kidney aging.

ROS related oxidative damage has been taken as a major threat of cell and tissue activity. Our in vitro assay indicated that the anti-aging effect of CBMSC-CM could be largely attributed to the improved cellular resistance to oxidative stress. In the immune system, H₂O₂ can act as a secondary messenger in the initiation and amplification of signaling at the antigen receptor⁴². Exposure to low concentration of H₂O₂ mimicked the effect of antigen and triggered proliferation of Jurkat cells. However, treatment of CBMSC-CM reduced the response sensitivity of T cells to H₂O₂. Given this result, CBMSC-CM may prohibit T cells exhaustion from persistent antigen stimulation and improve chronic infections. Furthermore, we also demonstrated that CBMSC-CM significantly attenuated oxidative stress induced cellular senescence and the related mechanism involved in the activation of the AKT signal.

In summary, our study provided the evidences that soluble factors secreted by CBMSCs ameliorate oxidative damage and attenuate the aging process of old tissues. These results emphasized the potential application of conditioned medium from MSCs in the therapy of aging and age-related diseases. The use of the conditioned medium as a cell-free strategy for therapy would significantly reduce the risk of allogeneic transplantation of MSCs.

Cell culture

Human umbilical cord blood samples were kindly donated from Jiangsu Yinfeng Biological Technology CO., Ltd (Nanjing, Jiangsu, China). Human mesenchymal stem cells from umbilical cord blood (CBMSC) were prepared as previously described ²¹. Briefly, the mononuclear cells were first separated by density-gradient centrifugation from umbilical cord blood. Then they were seeded into six-well plates at a density of 5×10⁶/well and cultured in DMEM/F12 medium (Wisent, Nanjing, JS, China) supplemented with 10% FBS (Wisent), 1% Penicillin/Streptomycin (Hyclone, Logan, UT, USA) and 2mM L-glutamine at 37℃ in 5% CO₂. Jurkat cells were maintained in RPMI1640 medium supplemented with 5% FBS, 1% Penicillin/Streptomycin (Hyclone) and 2mM L-glutamine at 37℃ in 5% CO₂ at a density of 10⁶ cells per ml.

Conditioned medium collection

To collect conditioned medium from CBMSCs (CBMSC-CM), CBMSCs before passage eight were cultured until 70% confluence. Then the cells were washed twice with PBS and further cultured with fresh DMEM/F12 medium for another 48 hours. Thereafter, the supernatant was collected. To remove cellular debris and extracellular vesicles, the supernatant was first centrifuged at 12,000×g for 30min, and then centrifuged at 100,000×g for 70min. Finally, the obtained supernatant was concentrated 15-fold using a 3KDa ultrafiltration membrane (Millipore, Bedfored, MA, USA) and stored at -80℃ until use.

Mice model

C57BL/6 male mice at 12 month old were used in this experiment. The ethical committee of ZhongDa hospital approved all animal procedures(No.20190307018). The mice were divided into control (n = 7) and CBMSC-CM treatment (n = 7) groups. They were intravenously injected with 200µl concentrated CBMSC-CM or control medium every three days for one month. Then, the mice were fed for another month until the following test.

Flow cytometry analysis

For the flow cytometry assay, the cells were assayed for fluorescence using an Accuri C6 cytometer (BD Bioscience, Ann Arbor, MI, USA). Data were analyzed using the Flowjo software (Tree Star, Inc., San Carlos, CA, USA).

To evaluate the immune cell phenotypes of old mice, the peripheral blood of mice was collected by submandibular bleeding. To analyze the expression of T cells, B cells, myeloid cells, natural killer cells (NK cells), regulatory T cells (Tregs), CD4 + naïve T cells and memory T cells, the blood samples were first blocked by purified anti-mouse CD16/32 antibody (Biolegend, San Diego, CA, USA) for 10 minutes on ice. Then they were stained with fuourescence-conjugated anti-mouse antibodies against CD3 (-PE), CD4 (-FITC), CD11b (-APC), CD19 (-FITC), CD335 (FITC), CD25 (-APC), CD44 (-PerCP-Cy5.5) and CD62L (-APC, all from Biolegend) for 20 minutes at room temperature in the dark and washed with PBS for two times. Thereafter, the blood samples were lysed by Red blood cell lysis buffer (eBioscience, San Diego, CA, USA) for eight minutes at room temperature in the dark, washed with PBS for two times. Finally, the samples were detected by flow cytometry.

Histological analysis

Tissues were embedded in OCT compounds and snap-frozen. Then the tissues were processed into 8-µm frozen sections using a cryotome and subsequently fixed with 100% acetone for two minutes. The sections were stored in -80℃ for further analysis. Histology examination was performed by staining the sections with hematoxylin and eosin (H&E) (Jiancheng Bio, Nanjing, JS, China).

Immunohistochemistry

Tissue sections were treated with 0.5% Triton-X100 in TBS buffer for 30 minutes and then washed with TBS buffer. The sections were blocked with 10% FBS and 1% BSA for two hours at room temperature. Then they were incubated with P16 antibody (1:50, Santa Cruz Biotech, Santa Cruz, CA, USA) at 4℃ overnight. After treated with 0.3% H₂O₂ in TBS buffer for 15 minutes, the sections were incubated with peroxidase-conjugated secondary antibody (Kangcheng Bio, Shanghai, China) for one hour at room temperature. Finally, the sections were visualized using a DAB kit (Beyotime) and assessed by microscopy.

Hydrogen peroxide treatment

Jurkat cells were pretreated with hydrogen peroxide (H₂O₂) with gradient concentrations (0µM, 5µM, 10µM, 15µM, 20µM, 50µM, 100µM, 150µM) for six hours. After discarding the old medium, the cells were resuspended with fresh medium and seeded into 96 well plate at a density of 2×10⁴/well. Then the cells were added with 10µl control or CBMSC-CM medium (10%) and incubated for another 18 hours.

CBMSCs were seeded into six-well plates until 50% confluence. Then they were treated with 200µM or 500µM hydrogen peroxide (H₂O₂) for two hours. After discarding old medium, the cells were washed three times with PBS. Finally, they were cultured with fresh medium containing CBMSC-CM or control medium and cultured for another three days.

Cell viability assay

The cell viability of jurkat cells were assayed by CCK8 reagent (Beyotime, Shanghai, China). Cells cultured in 96 well plate were treated with the indicated reagents and incubated for one hour. Cell viability was determined by the absorbance at 450nm wavelength (with reference wavelength of 650nm) measured using a microplate absorbance reader (Biotek, Winooski, VT, USA).

Reactive oxygen species detection

CBMSCs cultured in six-well plates were incubated with 5µM DCFH-DA (Beyotime, Shanghai, China) at 37℃ for 20 minutes. Then the cells were washed three times with fresh medium, digested with trypsin, and collected. Finally, the fluorescence was detected by flow cytometry.

SA-β-gal staining

SA-β-gal staining was performed using a SA-β-gal staining kit (Beyotime). Briefly, the cells or tissue sections were fixed using the fixation buffer for 15 minutes and then incubated with the staining solution at 37℃ overnight. The cells or sections were observed by microscopy. The ratio of positive cells was determined by counting the blue cells versus total cells.

Western blot

Total cell proteins were extracted using a total protein extraction kit (Sangon Biotech, Shanghai, China), resolved by 12% SDS-PAGE and transferred to PVDF membranes (Roche Diagnostics, Mannheim, Germany). Detection of protein expression was performed using anti-phospho-AKT1 (Ser473) (Thermo Fisher Scientific, Waltham, MA, USA), anti-AKT Pan (Thermo Fisher Scientific) and anti-GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA).

Statistical analysis

All data were expressed as the means ± SEM. Statistical analysis was performed using Graphpad prism (Graphpad Software. San Diego, CA, USA) and a two-tail student’s t test was used to compare two groups. A p value of less than 0.05 was considered statistically significant.

Acknowledgement: This work was financially supported supported by the National Natural Science Foundation of China (No. 81671807), the Key Research & Developement Program of Jiangsu Province (BE2020777) and Fundamental Research Funds for the Central Universities (2242018K3DN05) .

Author contributions: Bo Sun, Xianhui Meng and Yanlong Li performed the experiments, analyzed the data and wrote the main manuscript text. Zhongdang Xiao and Bo Sun designed the research and wrote the manuscript. All authors reviewed and approved the final manuscript.

Competing interests

The author(s) declare no competing interests.

1. Hunt, N. J., Kang, S. W. S., Lockwood, G. P., Le Couteur, D. G. & Cogger, V. C. Hallmarks of aging in the liver. Computational and structural biotechnology journal 17, 1151–1161 (2019).

2. Barbosa, M. C., Grosso, R. A. & Fader, C. M. Hallmarks of aging: an autophagic perspective. Frontiers in endocrinology 9, 790 (2019).

3. Chakravarti, D., LaBella, K. A. & DePinho, R. A. Telomeres: history, health, and hallmarks of aging. Cell (2021).

4. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).

5. Chung, H. Y. et al. Redefining chronic inflammation in aging and age-related diseases: proposal of the senoinflammation concept. Aging and disease 10, 367 (2019).

6. Duggal, N. A., Niemiro, G., Harridge, S. D., Simpson, R. J. & Lord, J. M. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity? Nature Reviews Immunology 19, 563–572 (2019).

7. Aiello, A. et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Frontiers in immunology 10, 2247 (2019).

8. Fulop, T. et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Frontiers in immunology 8, 1960 (2018).

9. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. science 284, 143–147 (1999).

10. Meirelles, L. da S., Chagastelles, P. C. & Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of cell science 119, 2204–2213 (2006).

11. Wang, J. et al. Characterization and therapeutic applications of mesenchymal stem cells for regenerative medicine. Tissue and cell 64, 101330 (2020).

12. da Silva Meirelles, L., Caplan, A. I. & Nardi, N. B. In search of the in vivo identity of mesenchymal stem cells. Stem cells 26, 2287–2299 (2008).

13. Yang, Y.-H. K., Ogando, C. R., See, C. W., Chang, T.-Y. & Barabino, G. A. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem cell research & therapy 9, 1–14 (2018).

14. Yang, Y.-H. K. Aging of mesenchymal stem cells: Implication in regenerative medicine. Regenerative therapy 9, 120–122 (2018).

15. Lau, A., Kennedy, B. K., Kirkland, J. L. & Tullius, S. G. Mixing old and young: enhancing rejuvenation and accelerating aging. The Journal of clinical investigation 129, 4–11 (2019).

16. Shen, J. et al. Transplantation of mesenchymal stem cells from young donors delays aging in mice. Scientific reports 1, 1–7 (2011).

17. Cao, N. et al. Clinical-grade human umbilical cord-derived mesenchymal stem cells reverse cognitive aging via improving synaptic plasticity and endogenous neurogenesis. Cell death & disease 8, e2996–e2996 (2017).

18. Fu, Y. et al. Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Engineering Part B: Reviews 23, 515–528 (2017).

19. Yuan, Q., Zhang, Y. & Chen, Q. Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine. The Anatomical Record 303, 1735–1742 (2020).

20. Wagner, W. et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem cells 25, 2638–2647 (2007).

21. Meng, X. et al. Comparative analysis of microRNA expression in human mesenchymal stem cells from umbilical cord and cord blood. Genomics 107, 124–131 (2016).

22. Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nature reviews immunology 8, 523–532 (2008).

23. Georgiev, P., Charbonnier, L.-M. & Chatila, T. A. Regulatory T cells: the many faces of Foxp3. Journal of clinical immunology 39, 623–640 (2019).

24. Arroyo Hornero, R., Hamad, I., Côrte-Real, B. & Kleinewietfeld, M. The Impact of Dietary Components on Regulatory T Cells and Disease. Frontiers in immunology 11, 253 (2020).

25. Hahn, H. J., Kim, K. B., An, I.-S., Ahn, K. J. & Han, H. J. Protective effects of rosmarinic acid against hydrogen peroxide‑induced cellular senescence and the inflammatory response in normal human dermal fibroblasts. Molecular medicine reports 16, 9763–9769 (2017).

26. Huang, Y.-H., Wu, P.-Y., Wen, K.-C., Lin, C.-Y. & Chiang, H.-M. Protective effects and mechanisms of Terminalia catappa L. methenolic extract on hydrogen-peroxide-induced oxidative stress in human skin fibroblasts. BMC complementary and alternative medicine 18, 1–9 (2018).

27. Sui, B.-D. et al. Stem cell-based bone regeneration in diseased microenvironments: challenges and solutions. Biomaterials 196, 18–30 (2019).

28. Asumda, F. Z. Age-associated changes in the ecological niche: implications for mesenchymal stem cell aging. Stem cell research & therapy 4, 1–11 (2013).

29. Kuhn, N. Z. & Tuan, R. S. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. Journal of cellular physiology 222, 268–277 (2010).

30. Le Garff-Tavernier, M. et al. Human NK cells display major phenotypic and functional changes over the life span. Aging cell 9, 527–535 (2010).

31. Huang, H., Patel, D. D. & Manton, K. G. The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci 10, 192–215 (2005).

32. Camous, X., Pera, A., Solana, R. & Larbi, A. NK cells in healthy aging and age-associated diseases. Journal of Biomedicine and Biotechnology 2012, (2012).

33. Solana, R., Campos, C., Pera, A. & Tarazona, R. Shaping of NK cell subsets by aging. Current opinion in immunology 29, 56–61 (2014).

34. Müller, L., Di Benedetto, S. & Pawelec, G. The immune system and its dysregulation with aging. Biochemistry and Cell Biology of Ageing: Part II Clinical Science 21–43 (2019).

35. Zhang, H., Puleston, D. J. & Simon, A. K. Autophagy and immune senescence. Trends in molecular medicine 22, 671–686 (2016).

36. Salminen, A. Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases. Journal of Molecular Medicine 1–20 (2020).

37. Madelung, C. F., Falk, M. K. & Sørensen, T. L. The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood. Clinical Ophthalmology (Auckland, NZ) 9, 1147 (2015).

38. Gliwiński, M., Piotrowska, M., Iwaszkiewicz-Grześ, D., Urban-Wójciuk, Z. & Trzonkowski, P. Therapy with CD4 + CD25 + T regulatory cells–should we be afraid of cancer? Contemporary Oncology 23, 1 (2019).

39. Lynch, H. E. et al. Thymic involution and immune reconstitution. Trends in immunology 30, 366–373 (2009).

40. Gasek, N. S., Kuchel, G. A., Kirkland, J. L. & Xu, M. Strategies for targeting senescent cells in human disease. Nature Aging 1, 870–879 (2021).

41. Ovadya, Y. et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nature communications 9, 1–15 (2018).

42. Di Marzo, N., Chisci, E. & Giovannoni, R. The role of hydrogen peroxide in redox-dependent signaling: homeostatic and pathological responses in mammalian cells. Cells 7, 156 (2018).

No competing interests reported.

suppl.informaitonSR.pdf

Download PDF

Version 1

posted

You are reading this latest preprint version

Conditioned medium from human cord blood mesenchymal stem cells attenuates age-related immune dysfunctions

Status:

Version 1

Abstract

Figures

Introduction

Results

Conditioned medium from CBMSCs improved immunoregulatory functions of middle-aged mice

Conditioned medium from CBMSCs ameliorated kidney aging of middle-aged mice

Conditioned medium from CBMSCs attenuated hydrogen peroxide triggered T cell response

Conditioned medium from CBMSCs attenuated oxidative stress-induced cellular senescence

Discussion

Materials And Methods

Cell culture

Conditioned medium collection

Mice model

Flow cytometry analysis

Histological analysis

Immunohistochemistry

Hydrogen peroxide treatment

Cell viability assay

Reactive oxygen species detection

SA-β-gal staining

Western blot

Statistical analysis

Declarations

References

Additional Declarations

Supplementary Files

Status:

Version 1